266 related articles for article (PubMed ID: 28797181)
1. HIV Resistance and Prevention of Mother-to-Child Transmission Regimen in HIV-Infected Infants in Northern Tanzania.
Dow DE; Schimana W; Nyombi BM; Mmbaga BT; Shayo AM; Bartlett JA; Massambu CG; Kifaro EG; Turner EL; DeMarco T; Cai F; Cunningham CK; Buchanan AM
AIDS Res Hum Retroviruses; 2017 Nov; 33(11):1107-1113. PubMed ID: 28797181
[TBL] [Abstract][Full Text] [Related]
2. Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique.
Antunes F; Zindoga P; Gomes P; Augusto O; Mahumane I; Veloso L; Valadas E; Camacho R
PLoS One; 2015; 10(7):e0131994. PubMed ID: 26161559
[TBL] [Abstract][Full Text] [Related]
3. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams E
Cochrane Database Syst Rev; 2014 May; 2014(5):CD004772. PubMed ID: 24852077
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 drug mutations in children from northern Tanzania.
Shao ER; Kifaro EG; Chilumba IB; Nyombi BM; Moyo S; Gaseitsiwe S; Musonda R; Johannessen A; Kibiki G; Essex M
J Antimicrob Chemother; 2014 Jul; 69(7):1928-32. PubMed ID: 24729604
[TBL] [Abstract][Full Text] [Related]
5. Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.
Fisher RG; Smith DM; Murrell B; Slabbert R; Kirby BM; Edson C; Cotton MF; Haubrich RH; Kosakovsky Pond SL; Van Zyl GU
J Clin Virol; 2015 Jan; 62():48-53. PubMed ID: 25542470
[TBL] [Abstract][Full Text] [Related]
6. Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India.
Kurle SN; Gangakhedkar RR; Sen S; Hayatnagarkar SS; Tripathy SP; Paranjape RS
AIDS Res Hum Retroviruses; 2007 May; 23(5):682-5. PubMed ID: 17530993
[TBL] [Abstract][Full Text] [Related]
7. Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.
Persaud D; Bedri A; Ziemniak C; Moorthy A; Gudetta B; Abashawl A; Mengistu Y; Omer SB; Isehak A; Kumbi S; Adamu R; Lulseged S; Ashworth R; Hassen E; Ruff A;
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):823-9. PubMed ID: 21241214
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
Penazzato M; Prendergast A; Tierney J; Cotton M; Gibb D
Cochrane Database Syst Rev; 2012 Jul; (7):CD004772. PubMed ID: 22786492
[TBL] [Abstract][Full Text] [Related]
10. Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxis.
Nelson JA; Fokar A; Hudgens MG; Compliment KJ; Hawkins JT; Tegha G; Kamwendo DD; Kayira D; Mofolo IA; Kourtis AP; Jamieson DJ; Van Der Horst CM; Fiscus SA
AIDS; 2015 Oct; 29(16):2131-8. PubMed ID: 26186128
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13.
Hunt GM; Ledwaba J; Salimo A; Kalimashe M; Dinh TH; Jackson D; Sherman G; Puren A; Ngandu NK; Lombard C; Morris L; Goga A
BMC Infect Dis; 2019 Sep; 19(Suppl 1):787. PubMed ID: 31526373
[TBL] [Abstract][Full Text] [Related]
12. Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.
van Zyl GU; Claassen M; Engelbrecht S; Laten JD; Cotton MF; Theron GB; Preiser W
J Med Virol; 2008 Jun; 80(6):942-6. PubMed ID: 18428139
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.
Zeh C; Weidle PJ; Nafisa L; Lwamba HM; Okonji J; Anyango E; Bondo P; Masaba R; Fowler MG; Nkengasong JN; Thigpen MC; Thomas T
PLoS Med; 2011 Mar; 8(3):e1000430. PubMed ID: 21468304
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission.
Samuel R; Julian MN; Paredes R; Parboosing R; Moodley P; Singh L; Naidoo A; Gordon M
J Acquir Immune Defic Syndr; 2016 Dec; 73(4):384-389. PubMed ID: 27327263
[TBL] [Abstract][Full Text] [Related]
15. Low-frequency nevirapine resistance at multiple sites may predict treatment failure in infants on nevirapine-based treatment.
Lehman DA; Wamalwa DC; McCoy CO; Matsen FA; Langat A; Chohan BH; Benki-Nugent S; Custers-Allen R; Bushman FD; John-Stewart GC; Overbaugh J
J Acquir Immune Defic Syndr; 2012 Jul; 60(3):225-33. PubMed ID: 22395670
[TBL] [Abstract][Full Text] [Related]
16. Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.
Han J; Wang L; Jiang Y; Zhang Q; Fang L; Yao J; Wang Q
Int J STD AIDS; 2009 Apr; 20(4):249-54. PubMed ID: 19304969
[TBL] [Abstract][Full Text] [Related]
17. Emergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmission.
Hauser A; Sewangi J; Mbezi P; Dugange F; Lau I; Ziske J; Theuring S; Kuecherer C; Harms G; Kunz A
PLoS One; 2012; 7(2):e32055. PubMed ID: 22384138
[TBL] [Abstract][Full Text] [Related]
18. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
Eshleman SH; Mracna M; Guay LA; Deseyve M; Cunningham S; Mirochnick M; Musoke P; Fleming T; Glenn Fowler M; Mofenson LM; Mmiro F; Jackson JB
AIDS; 2001 Oct; 15(15):1951-7. PubMed ID: 11600822
[TBL] [Abstract][Full Text] [Related]
19. Non-nucleoside reverse transcriptase inhibitor levels among HIV-exposed uninfected infants at the time of HIV PCR testing - findings from a tertiary healthcare facility in Pretoria, South Africa.
Mazanderani AH; Murray TY; Sherman GG; Snyman T; George J; Avenant T; Goga AE; Pepper MS; du Plessis N
J Int AIDS Soc; 2019 Jun; 22(6):e25284. PubMed ID: 31215757
[TBL] [Abstract][Full Text] [Related]
20. Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART.
MacLeod IJ; Rowley CF; Thior I; Wester C; Makhema J; Essex M; Lockman S
J Clin Virol; 2010 Jul; 48(3):162-7. PubMed ID: 20427228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
